NEXGEL (NXGL) Competitors $2.80 -0.03 (-1.20%) As of 04/17/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. NSPR, SRTS, MLSS, ZYXI, CTSO, ICCM, VANI, INO, NTRB, and GUTSShould you be buying NEXGEL stock or one of its competitors? The main competitors of NEXGEL include InspireMD (NSPR), Sensus Healthcare (SRTS), Milestone Scientific (MLSS), Zynex (ZYXI), Cytosorbents (CTSO), IceCure Medical (ICCM), Vivani Medical (VANI), Inovio Pharmaceuticals (INO), Nutriband (NTRB), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry. NEXGEL vs. InspireMD Sensus Healthcare Milestone Scientific Zynex Cytosorbents IceCure Medical Vivani Medical Inovio Pharmaceuticals Nutriband Fractyl Health NEXGEL (NASDAQ:NXGL) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, dividends, profitability, valuation, risk, media sentiment and analyst recommendations. Do institutionals and insiders hold more shares of NXGL or NSPR? 2.2% of NEXGEL shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 24.9% of NEXGEL shares are owned by insiders. Comparatively, 29.7% of InspireMD shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility and risk, NXGL or NSPR? NEXGEL has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Which has better earnings and valuation, NXGL or NSPR? NEXGEL has higher revenue and earnings than InspireMD. NEXGEL is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNEXGEL$8.69M2.49-$3.16M-$0.50-5.66InspireMD$7.01M10.97-$19.92M-$0.78-3.32 Is NXGL or NSPR more profitable? NEXGEL has a net margin of -52.60% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat NEXGEL's return on equity.Company Net Margins Return on Equity Return on Assets NEXGEL-52.60% -71.19% -34.79% InspireMD -413.96%-69.42%-57.68% Does the MarketBeat Community favor NXGL or NSPR? InspireMD received 3 more outperform votes than NEXGEL when rated by MarketBeat users. However, 50.00% of users gave NEXGEL an outperform vote while only 4.08% of users gave InspireMD an outperform vote. CompanyUnderperformOutperformNEXGELOutperform Votes150.00% Underperform Votes150.00% InspireMDOutperform Votes44.08%Underperform Votes9495.92% Does the media refer more to NXGL or NSPR? In the previous week, NEXGEL had 1 more articles in the media than InspireMD. MarketBeat recorded 2 mentions for NEXGEL and 1 mentions for InspireMD. InspireMD's average media sentiment score of 0.59 beat NEXGEL's score of -1.00 indicating that InspireMD is being referred to more favorably in the news media. Company Overall Sentiment NEXGEL Negative InspireMD Positive Do analysts prefer NXGL or NSPR? InspireMD has a consensus target price of $4.75, indicating a potential upside of 83.40%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than NEXGEL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryInspireMD beats NEXGEL on 11 of the 18 factors compared between the two stocks. Get NEXGEL News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNEXGELSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.66M$4.04B$5.30B$7.35BDividend YieldN/A46.44%5.45%4.30%P/E Ratio-4.8827.6821.8617.81Price / Sales2.4947.06380.6697.70Price / CashN/A51.0838.2634.64Price / Book3.145.816.453.98Net Income-$3.16M$67.09M$3.22B$247.81M1 Month Performance1.43%-11.64%-9.75%-7.92%1 Year Performance30.41%14.55%11.50%1.52% NEXGEL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNEXGEL0.4238 of 5 stars$2.83flatN/A+28.3%$21.66M$8.69M-4.8810Short Interest ↑Gap DownNSPRInspireMD2.1151 of 5 stars$2.59-1.9%$4.75+83.4%+22.2%$76.90M$7.01M-3.4550Analyst ForecastSRTSSensus Healthcare2.5723 of 5 stars$4.48+0.4%$13.00+190.2%+41.2%$73.90M$41.81M11.2040Gap DownMLSSMilestone Scientific2.0195 of 5 stars$0.89+2.3%$1.25+40.4%+57.7%$69.32M$8.88M-12.7130Analyst ForecastNews CoverageGap UpZYXIZynex3.0295 of 5 stars$2.16flat$10.25+374.5%-81.0%$65.29M$192.35M14.40770Analyst ForecastGap DownHigh Trading VolumeCTSOCytosorbents1.7495 of 5 stars$0.99+2.1%$4.67+371.1%+28.6%$61.91M$35.59M-2.75220Analyst ForecastPositive NewsICCMIceCure Medical1.6043 of 5 stars$1.11-2.6%$2.50+125.2%-8.5%$61.61M$3.29M-3.8360Positive NewsVANIVivani Medical2.612 of 5 stars$1.02+6.3%$4.00+292.2%-41.3%$60.42MN/A-2.2720Analyst ForecastShort Interest ↑Gap UpINOInovio Pharmaceuticals3.2343 of 5 stars$1.58+1.3%$12.20+672.2%-82.9%$57.93M$217,756.00-0.40320Analyst UpgradeShort Interest ↑Gap DownHigh Trading VolumeNTRBNutriband2.7569 of 5 stars$5.09-5.7%$13.00+155.4%+25.0%$56.53M$2.02M-7.1710Gap DownGUTSFractyl Health1.7173 of 5 stars$1.07-4.5%$10.00+834.6%-81.4%$54.79M$93,000.00-0.09102Analyst ForecastNews CoverageHigh Trading Volume Related Companies and Tools Related Companies NSPR Alternatives SRTS Alternatives MLSS Alternatives ZYXI Alternatives CTSO Alternatives ICCM Alternatives VANI Alternatives INO Alternatives NTRB Alternatives GUTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NXGL Stock Free NXGL Stock Alerts